文献速递眼底病与葡萄膜炎

Epac1上调通过诱导线粒体分裂、活性氧产生和凋亡促进周细胞丢失

Upregulation of Epac1 Promotes Pericyte Loss by Inducing Mitochondrial Fission, Reactive Oxygen Species Production, and Apoptosis.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2023-01-01

本研究利用小鼠视网膜缺血再灌注损伤和链脲佐菌素诱导的1型糖尿病模型,以及Epac1基因敲除小鼠,探讨Epac1信号在缺血性视网膜病变周细胞损伤中的作用;并在一原代人视网膜周细胞中通过RNA干扰和药理学抑制剂调控Epac1活性,研究高糖环境下Epac1介导周细胞功能障碍的细胞与分子机制。结果显示缺血损伤或糖尿病诱导的视网膜毛细血管变性伴随视网膜血管系统(包括内皮细胞和周细胞)Epac1表达增加;Epac1基因缺失可保护缺血损伤诱导的小鼠视网膜周细胞丢失和毛细血管变性;高糖诱导的视网膜周细胞Epac1表达伴随Drp1磷酸化、线粒体分裂、活性氧产生和caspase 3激活增加;通过RNA干扰或药理学方法抑制Epac1可阻断高糖介导的线粒体功能障碍和caspase 3激活。结论表明Epac1信号在视网膜周细胞线粒体动力学、活性氧产生和凋亡中起重要作用,并确定Epac1为治疗缺血性视网膜病变的治疗靶点。

要点

  • 缺血损伤或糖尿病诱导的小鼠视网膜毛细血管变性伴随视网膜血管系统Epac1表达增加。
  • Epac1基因缺失保护缺血损伤诱导的小鼠视网膜周细胞丢失和毛细血管变性。
  • 抑制Epac1可阻断高糖介导的视网膜周细胞线粒体功能障碍和caspase 3激活。

核心结论

  • Epac1信号在视网膜周细胞线粒体动力学、活性氧产生和凋亡中起重要作用,Epac1被确定为治疗缺血性视网膜病变的治疗靶点。

研究设计与样本

  • 研究使用小鼠视网膜缺血再灌注损伤模型和链脲佐菌素诱导的1型糖尿病模型,以及Epac1基因敲除小鼠模型。
  • 在一原代人视网膜周细胞中通过Epac1特异性RNA干扰和药理学抑制剂调控Epac1活性,研究高糖环境下Epac1介导周细胞功能障碍的细胞与分子机制。

主要发现

  • 缺血损伤或糖尿病诱导的视网膜毛细血管变性伴随小鼠视网膜血管系统(包括内皮细胞和周细胞)Epac1表达增加。
  • Epac1基因缺失保护缺血损伤诱导的小鼠视网膜周细胞丢失和毛细血管变性。
  • 高糖诱导的视网膜周细胞Epac1表达伴随Drp1磷酸化、线粒体分裂、活性氧产生和caspase 3激活增加。
  • 通过RNA干扰或药理学方法抑制Epac1可阻断高糖介导的线粒体功能障碍和caspase 3激活。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The pathogenic mechanisms behind the development of ischemic retinopathy are complex and poorly understood. This study investigates the involvement of exchange protein directly activated by cAMP (Epac)1 signaling in pericyte injury during ischemic retinopathy, including diabetic retinopathy, a disease that threatens vision. METHODS: Mouse models of retinal ischemia-reperfusion injury and type 1 diabetes induced by streptozotocin were used to investigate the pathogenesis of these diseases. The roles of Epac1 signaling in the pathogenesis of ischemic retinopathy were determined by an Epac1 knockout mouse model. The cellular and molecular mechanisms of Epac1-mediated pericyte dysfunction in response to high glucose were investigated by specific modulation of Epac1 activity in primary human retinal pericytes using Epac1-specific RNA interference and a pharmacological inhibitor. RESULTS: Ischemic injury or diabetes-induced retinal capillary degeneration were associated with an increased expression of Epac1 in the mouse retinal vasculature, including both endothelial cells and pericytes. Genetic deletion of Epac1 protected ischemic injury-induced pericyte loss and capillary degeneration in the mouse retina. Furthermore, high glucose-induced Epac1 expression in retinal pericytes was accompanied by increased Drp1 phosphorylation, mitochondrial fission, reactive oxygen species production, and caspase 3 activation. Inhibition of Epac1 via RNA interference or pharmacological approaches blocked high glucose-mediated mitochondrial dysfunction and caspase 3 activation. CONCLUSIONS: Our study reveals an important role of Epac1 signaling in mitochondrial dynamics, reactive oxygen species production, and apoptosis in retinal pericytes and identifies Epac1 as a therapeutic target for treating ischemic retinopathy.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Yang W, Xia F, Mei F, et al. Upregulation of Epac1 Promotes Pericyte Loss by Inducing Mitochondrial Fission, Reactive Oxygen Species Production, and Apoptosis. Invest Ophthalmol Vis Sci. 2023. PMID: 37651112. doi:10.1167/iovs.64.11.34

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。